# A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)

> **NCT02460159** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 135 (actual)

## Conditions studied

- Hypercholesterolemia
- Heterozygous Familial Hypercholesterolemia

## Interventions

- **DRUG:** EZ 10 mg/Atorva 20 mg FDC
- **DRUG:** EZ 10 mg/Atorva 10 mg FDC

## Key facts

- **NCT ID:** NCT02460159
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-23
- **Primary completion:** 2016-12-22
- **Final completion:** 2016-12-22
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02460159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02460159, "A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02460159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*